STOCK

MLTX MOONLAKE IMMUNOTHERAPEUTICS

Held by 10 of 73 curated managers · 10 total holders in our 13F universe.

FUNDAMENTALS
Market Cap $1.6B
P/E (Trailing)
P/E (Forward) -5.55
PEG Ratio
Price/Book 5.31
Profit Margin 0.0%
Gross Margin 0.0%
Revenue Growth YoY
Earnings Growth YoY
Dividend Yield 0.0%
52-Week Range $5.95 – $62.75

Fundamentals: Yahoo Finance · cached · Jul 29, 2026

SMART MONEY HOLDERS · from our curated set

Top managers holding MLTX

  1. ADAR1 Capital Management, LLC Biotech picker with seventy-four percent alpha.
    Top performer
    0.5% of portfolio
  2. Two Sigma Investments, LP Quantitative arbitrage. Zero alpha. Known entity.
    Name to know Mega
    0.0% of portfolio
  3. Citadel Advisors LLC Citadel — systematic quantitative dominance.
    Name to know Mega
    0.0% of portfolio
  4. WINTON GROUP Ltd Berkshire proxy with modest alpha generation.
    Top performer
    0.0% of portfolio
  5. Renaissance Technologies LLC Quant. Different beast — opt in or out.
    Thematic Mega
    0.0% of portfolio
  6. Tudor Investment Corp. Et Al Broad market tracker with modest leverage.
    Name to know Mega
    0.0% of portfolio
  7. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Mega-cap tech concentration. Outsized alpha generation.
    Top performer
    0.0% of portfolio
  8. Citigroup Inc. Tech mega-cap concentration. Outperformance through concentration.
    Top performer
    0.0% of portfolio
  9. Vanguard Group Inc. Passive indexer with modest active tilts.
    Name to know Mega
    0.0% of portfolio
  10. State Street Corp. Index tracker with mega-cap tech tilt.
    Name to know Mega
    0.0% of portfolio
EDITORIAL BRIEF

The editorial brief for MLTX is being prepared. Stock briefs roll out across Q3 starting with the most-held names.

INSIDER TRADES · recent
  • Bvf Partners L P/Il Mar 31, 2026 SELL $32.44M
  • Bvf Partners L P/Il Mar 31, 2026 SELL $26.35M
  • Chen Bihua Sep 29, 2025 SELL $25.70M
  • Chen Bihua Sep 29, 2025 SELL $18.51M
  • Bvf Partners L P/Il Mar 31, 2026 SELL $4.17M
CONGRESS TRADES · recent

No STOCK Act trades on file for MLTX.